Sassicaia Capital Advisers »

Intensity Therapeutics shares owned by Sassicaia Capital Advisers

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Sassicaia Capital Advisers from 13F filings

Historical chart of Sassicaia Capital Advisers investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Sassicaia Capital Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Sassicaia Capital Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.9k 20k 0.24

More positions owned by Sassicaia Capital Advisers

NVIDIA Corporation (NVDA)
Pfizer (PFE)
Robinhood Mkts Com Cl A (HOOD)
Spdr Gold Tr Gold Shs (GLD)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Coreweave Com Cl A (CRWV)
Target Corporation (TGT)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bloom Energy Corp Com Cl A (BE)
Warner Bros Discovery Com Ser A (WBD)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)
Volatility Shs Tr 2x Ether Etf New (ETHU)
Apple (AAPL)

View all positions for Sassicaia Capital Advisers

Top funds holding Intensity Therapeutics

Sapient Capital
Sentinus
Geode Capital Management
Vanguard Group
Mesirow Financial Investment Management International Equity
UBS Group
Brown Advisory Holdings Incorporated
Sigma Planning
Warberg Asset Management
Stonebridge Financial Group
IHT Wealth Management
William Blair $ Company
One Charles Private Wealth Services
Virtu Financial
Scientech Research

View all funds holding Intensity Therapeutics